Konstantinopoulos, Panagiotis A <br/><br/>
PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair.  [electronic resource] 

 -  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting  Mar 2020 
 - 1-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1548-8756 
<br/><br/><label>Standard No.: </label>10.1200/EDBK_288015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>DNA Damage<br/>DNA Repair<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Ovarian Neoplasms--drug therapy<br/>Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use